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Abstract
Nodding syndrome (NS) is a devastating childhood neurological disorder seen in
clusters in Eastern Africa but of uncertain nosology. It is characterized by repetitive
head nodding, atonic seizures, cognitive decline, and school dropout, wasting and
stunted growth and it occurs in children subject to internal displacement, food
insecurity, and exposure to infectious diseases, contaminated environment and
with a number of repetitive behavioral abnormalities. On the other hand autism
spectrum disorders (ASD) is a group of behaviorally defined neurodevelopmental
disorders with lifelong consequences. They are defined by impairments in commu-
nication and social interaction along with restrictive and repetitive behaviors. It is a
complex disorder associated with a wide range of disparate and seemingly unrelated
factors such as; maternal exposure to various chemical substances, maternal expo-
sure to child abuse, maternal evidence of Diabetes, autoimmune diseases, age of
either parents at conception, exposure of infants to various chemical substances,
low vitamin D levels of the infant at birth, gender of the infant and a large number
of genetic factors. There are a number of similarities in the clinical, biochemical and
behavioral findings in children with NS and ASD.
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1. Introduction
Nodding syndrome (NS) is a devastating childhood neurological disorder of
uncertain nosology [1]. The syndrome is characterized by atonic seizures, head
nodding, cognitive decline, muscle weakness, school dropout, thermal dysfunction,
internal displacement, food insecurity, wasting, stunted growth, exposures to
infectious diseases, contaminated environment and with a number of repetitive
behavioral abnormalities [1, 2]. It occurs in clusters in three Eastern African coun-
tries (Uganda, Tanzania and South Sudan) and has spatial temporality and clustered
in time (during IDP period), space (clustered on either sides of the two main
rivers of Aswa and Pager) and person (mainly at 5–15 years of age at onset)
particularly in Northern Uganda [3]. The syndrome was first described in 1st
scientific meeting organized by the Ugandan Ministry of Health (MOH) and World
Health Organization (WHO) in Sheraton, Kampala, Uganda in 2012 [4]. The
outcome of the meeting was the agreed WHO epidemiological and surveillance
case definition of probable nodding syndrome [5, 6]. It states, “Probable NS cases
should meet the following criteria:
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• Reported head nodding in a previously normal person who have been observed
and recorded by a trained healthcare worker.
• Head nodding is defined as repetitive, involuntary drops of the head to the
chest on two or more occasions.
• Age at onset of nodding between 3 and 18 years old.
• Frequency of nodding 5 to 20 per minute.
• Plus at least one of the following criteria:
• Other neurological abnormalities (cognitive decline, school dropout due
to cognitive/behavioral problems, other seizures or neurological
abnormalities).
• Clustering in space or time with similar cases.
• Triggered by food and/or cold weather.
• Stunting or wasting.
• Delayed sexual or physical development.
• Psychiatric symptoms.”
In addition, it has been observed that nodding episodes were stimulated by
sights of local food, starvation, exposure to cold weather/temperatures, cold water,
stress, physical exercises and there was an association with high anion gap and that
most NS began in the internally Displaced Peoples camps (IDPs) or immediately
after resettlement into the satellite camps and eventually to their original villages
[1–5]. Researchers propose that NS is an emerging neurological disorder in Eastern
Africa likely due to factors that were experienced during the IDPs [1, 3–5] and
that no new NS cases have been reported since 2012 by the Ugandan Ministry of
Health (MOH) and WHO after the IDP camps were disbanded and the affected
communities resettled in their villages [1, 3, 5].
Some authors have suggested that nodding syndrome may perhaps be similar to
a psychogenic disease (psychogenic illness) in which physical illnesses that are
believed to arise from emotional or mental stressors or from psychological or psy-
chiatric disorders may have resulted from the 20 year old civil war that occurred in
Northern Uganda. Psychogenic diseases are most commonly applied to illnesses
where there is a physical abnormality and other biomarker has not yet been identi-
fied as observed in children with NS. Interestingly, the onset of NS perhaps has
some similarities to a mass psychogenic illness which involves rapid spread of
illness, signs and symptoms affecting a cohesive group originating from a nervous
system disturbance involving seizures, loss/reduction of cognitive function with
emotional and behavioral abnormalities.
However, findings in NS children contrasts greatly from epidemic hysteria,
psychogenic contagion, imitation as perhaps observed among some NS families
where two or more children in the same family were affected with the syndrome.
Important to note was that all the children that developed NS in the same family did
not show evidence of hysterical behavior but physical signs and symptoms that
seems to arise from a common experience during the IDPs. Each NS child’s
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presentation vary from each other and perhaps reflecting the spectrum nature of NS
occurrence from the most severe to mild form. It was also noted that the course of
the NS illness was greatly altered and improved by early initiation of medical
intervention on the affected NS child.
The most recent findings through an extensive histoimmunochemistry of brains
of deceased nodding syndrome children have revealed that Nodding Syndrome is a
tauopathy [7]. This draws more attention to the possibility of diet and environmen-
tal exposures of NS children as the likely source of the pathology [3].
Interestingly, all communities where NS occur at epidemic proportion experi-
enced some degree of internal displacement before the onset of NS [2, 3, 5]. In
addition, there is a widely held belief among the affected communities in Northern
Uganda that NS had possibly originated from contaminated relief food provided
during IDPs or exposure to war munitions/chemicals during the protracted 20 year
old war in Northern Uganda between the rebel, Lord’s Resistance Army (LRA)
and the Government of Uganda where 90% of the population in Acholi were
displaced into IDPs [8, 9]. Some studies have reported consumption of spoiled relief
foods by NS children while in IDPs but there are no mentions of the proportions
of NS children that ate it [10–14]. Furthermore, Researchers have extensively
investigated cause(s) of NS due to infectious agents but with no single cause that
have so far been confirmed [1, 10]. In particular, studies from Northern Uganda
have identified high Anion gap metabolic acidosis among NS children compared to
their sex and age matched controls [1, 6, 10, 15]. These findings suggested perhaps
that NS could be secondary to a metabolic disorder and perhaps a mitochondrial
disorder [1, 6, 10, 15]. In addition, researchers observed that nodding episodes were
precipitated by sights of local food, starvation, exposure to cold weather/tempera-
tures or cold water, stress, excess physical exercises and there was a statistically
significant association with high anion gap [1, 6, 10, 15]. Other researchers
suggested that since the IDPs were disbanded, no new NS cases were reported when
the affected communities resettled in their villages and feed on their home grown
foods [2, 6, 8, 15] an indication that perhaps the factors that led to the onset of the
syndrome were removed by moving the communities from the agents that may
have been involved in its etiology.
In a recent case control study, researchers found a statistically significant asso-
ciation between NS and biotinidase and acetyl carnitine deficiencies [16]. In addi-
tion, other studies had previously observed a deficiency in Vitamin B6 [15] and
Vitamin D in NS children [17, 18]. All these findings may suggest perhaps that NS
could be secondary to a metabolic disorder and perhaps a mitochondrial disorder
may be one of the factors [1, 3–6, 10, 16]. Interestingly, recent data on NS children
in a study conducted by a team of researchers from the US funded by National
Institute of Health (NIH) suggested an association between NS with cerebrospinal
fluid (CSF) VGKC antibodies [19] and serum leiomidin-1 antibody, suggesting a
neuroinflammatory cause [20]. All these findings give credence to an emerging
neurological disorder which is devastating the lives of many young people in East-
ern Africa and that there is no single identifiable marker and that management and
prevention strategies have remained elusive.
On the other hand, autism spectrum disorders (ASD) is a group of behaviorally
defined neurodevelopmental disorders with lifelong consequences [21]. They are
defined by impairments in communication and social interaction along with
restrictive and repetitive behaviors [21]. Autism spectrum disorder is now esti-
mated to affect 1 out of 68 individuals in the United States with approximately
four times more males than females being affected [22]. Although ASD is behavior-
ally defined, children with ASD also have many co-occurring medical conditions
such as gastrointestinal abnormalities [23], seizures and epilepsy [24], attention
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deficits [25], anxiety disorders [26] and allergies [27]. It is reported that one of the
most significant co morbidities associated with ASD that causes significant disabil-
ity is epilepsy [28] and a number of studies have suggested that epilepsy affects a
high proportion of individuals with ASD [28]. In addition, a number of risk factors
for autism can be categorized as risk factors for inflammation or indicators of
inflammation [28] which seems to be similar to the factors suggested in the etiology
of nodding syndrome.
2. Nodding syndrome and displacement into IDP camps
Several epidemiological studies in Uganda show NS clustered in time (IDP camp
period); space (Geographically located on either side of two major rivers (Aswa &
Pager) and in person (NS onset is mainly between ages of 5–15 years) [2, 3, 29].
There is an association between life in the IDP camps and onset of NS [2–4, 29].
Historically from 1986 to 2007/2008, Northern Uganda experienced a civil war
between the Ugandan Army and rebel groups [2, 30]. Starting in mid-1990s, IDP
camps were established in some parts of Northern Uganda with the goal of
protecting the population and with an estimated 285,000 people from Kitgum
District displaced into IDPs [2, 31, 32]. In the period before displacement into IDPs,
there were no reported cases of NS [2]. Similarly in 2001, another community of
Aromowanglobo in Awere sub county, Gulu District were moved into IDPs where
many of them became dependent on food rations supplied by the relief agencies
[3, 33]. IDP camps became associated with malnutrition, social norm breakdown,
rising incidence of alcoholism, mental health disorders, suicidal tendencies,
increasing prevalence of HIV, Cholera, Hepatitis B & E and other infectious dis-
eases, neglect and waste of the youths [2–4, 29]. The IDPs began to be disbanded in
late 2006 when the LRA retreated to South Sudan but during the height of the
insurgency in 2002 over 1.5 million people were displaced in the Acholi sub region
and thus accounting for over 90% of the population [31, 32]. After 2007, the
Government began returning the displaced people into their homes in a phase-wise
approach from the main IDPs to satellite camps near their villages [2, 31, 32].
Eventually by 2010, the communities were returned to their original homes in their
farmland where the returnees were to settle and rebuild their lives [2–4, 31, 32].
In 2009, the Ugandan Ministry of Health (MOH) identified NS in communities
in Northern Uganda and later on established NS screening and rehabilitation centers
in 2012 where NS children were treated with anticonvulsants, multivitamins and
nutritional supplements [3, 5, 6, 10, 19, 29]. The consistency of supplies and reha-
bilitation processes faced challenges including irregular supply of anticonvulsants
and food for NS children and the vulnerable families [2, 8, 9, 31, 32]. In the
same period, there was an apparent relationship between the peaks of NS cases in
Kitgum District and earlier peak influxes of households into IDPs [2] which was
similarly observed in Awere Sub County in Gulu district [3]. Important to note was
that the 1997 peak influx of IDPs in Kitgum District was followed 7 years later by
an elevated number of new NS cases in 2004 (2003–2005) and similarly in the 2003
large influx of households had a larger peak in new NS cases 5 years later in 2008
[2]. This was similarly observed in Awere in Gulu where the 2001–2002 influxes
were followed with increased incidences of NS, 7 years later in 2008–2009 [3]. The
peaks of reported NS onset correlated with peaks of household displacement and
food insecurity, where residents were heavily dependent on food aid from relief
agencies [2, 3, 29, 31–34]. The IDP camps were exceptionally poor, insecure,
unsanitary, with overcrowding, violence, food insecurity and squalid, and morbid-
ity and mortality rates were high [2, 35].
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In 2005, a Government survey of Kitgum district estimated an IDP population of
310,111 persons; 21% of whom were children under 5 years [2]. At the time of the
survey, over 66% of children were reported to have been ill sometime in the
previous 2 weeks and the crude mortality rates were reported to be 2 deaths per
10,000 per day and double that rate for children under the age of 5 years [2, 29, 35].
In addition, the top self-reported causes of death in IDPs were malaria/fever
(34.7%), AIDS (15.1%) and violence (10.5%) [2] and water was obtained from
protected sources but water intake was low and the waiting time was high and the
infant feeding practices were poor [2]. It is reported that for children under the age
of 5 years, the traditional disease concept of “Two Lango” or “Gin pa Omiru”
which was a combination of oral thrush, malnutrition and diarrhea was the second
most commonly reported causes of death [2, 34]. These findings were thorough
analysis of the events in all IDPs across the Acholi and Lango sub regions where NS
occurred at epidemic proportions.
3. Epidemiological, environmental and dietary findings on nodding
syndrome children
Studies show that NS in Awere, Gulu district, Northern Uganda was first noted
in 2002 which corresponded with 1 year stay in IDPs [3]. The month of peak
incidence of NS onset was April and October [3]. These peaks corresponded fairly
with the peaks of monthly average rainfall for 1st and 2nd rainy seasons [3] and
related to scarcity of food as observed by Landis et al. [2]. The factors around the
syndrome onset could have perhaps been in IDPs since all NS children were in IDPs
before onset of nodding [2, 3, 29]. The other reason could perhaps be that NS
children who were born before IDPs, had developed NS earlier except, the condi-
tion was not detected or overtly manifested but that the IDP camp conditions
precipitated its overt manifestation perhaps coupled with other stressor factors such
as Onchocerca Volvulus (OV) infection; malnutrition, war trauma and febrile ill-
nesses [1–5, 29]. In addition, most NS children were in 1st, 2nd and 3rd birth orders
in descending orders respectively [3, 5] and all of them experienced IDP life which
peaked at 5 years of IDP stay [3]. Additionally, most NS children have other siblings
with NS and its occurrence in siblings mirrored NS children’s birth orders [3]. This
finding, perhaps point towards a possibility of an acquired disease which was
overtly manifested possibly as a result of family/household factors such as; poor
storage of food leading to contamination and/or infection with OV or stress which
made the syndrome perhaps manifestly overt on exposure to these factors [3, 5].
Perhaps the perfect examples of such could be seen in deficiencies of metabolites in
acquired diseases whose disease occurrence becomes overtly expressed in circum-
stances of stress [36]. That could perhaps explain why there are no new NS cases
since 2012 when the communities were resettled in their villages and feed on their
own home grown foods [3, 19, 29, 37].
In general, the information provided by parents of NS children show that NS
children were all reported to have been born normal and that the developmental
milestones were normal until NS began [1, 3, 5, 29, 37, 38]. Before onset of nodding,
food listed in [3, 5] were the supplementary and weaning foods that were supplied
by relief agencies and eaten by the IDPs residents including NS children [31]. The
quantity and duration of these food ration eaten by each NS child could however,
not be determined but report on it was provided by the World Food Program
(WFP) [31, 32].
Interestingly in 2012 when some NS children were examined before admission
to the Hope for HumaNs (HfH) centre for NS rehabilitation, they were diagnosed
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mostly with Severe Acute Malnutrition (SAM) and a few with Moderate Acute
Malnutrition (MAM) respectively on the basis of their z-scores [38]. Upon enrol-
ment for a multidisciplinary and syndromic treatment with anticonvulsants, multi-
vitamins, local food supplements, and psychosocial support; their health conditions
greatly improved, seizure frequency reduced, mental health status improved, cog-
nitive impairment improved, they gained weight and height and by 2014 when the
author re-assessed these NS children in a longitudinal study, most of them had
improved and categorized as MAM and healthy nutritionally [5, 29, 38, 39]. This
observation was perhaps due to good feeding program at the HfH centre and
adequate rehabilitation processes accorded to NS children. However, much as they
had improved and some had returned to school, none of them could be declared
cured because they still experienced sporadic episodes of nodding, emotional and
perceptual disturbances and some cognitive impairment [5, 10, 29, 38, 39].
4. Biotinidase and acetyl carnitine deficiency, nodding syndrome and
metabolic disorder
In one of the pilot studies conducted on NS children in Northern Uganda, it was
observed that most NS children demonstrated a deficiency of biotinidase enzyme
activity ranging from 0 to 100% [16]. The average percentage deficiency was 78%
(78 SD  13.362), an indication that this enzymatic deficiency was a spectrum
which varied considerably from one NS child to another depending on the percent-
age deficiency of biotinidase activity [40–43] just like the severity and clinical pre-
sentations of NS varied from one child to another [5]. Biotinidase deficiency has
commonly been classified as partial or profound deficiency whereby the clinical
presentations and occurrence depended on the percentage deficiency and the pres-
ence of stressor factors [40–43]. It is reported that partial biotinidase deficiency is a
milder form of this condition in which without treatment with biotin, the affected
child may experience hypotonia, skin rashes and hair loss, but these problems may
appear only during illness, infections, or other times of stress [40–43]. These
authors suggest that NS occurs as a spectrum similarly to biotinidase deficiency and
that for NS children that had partial biotinidase deficiency, they experienced severe
stress (Malnutrition, psychological stress and OV infection) that resulted into the
overt presentation of NS [16]. The stressors in this case could have perhaps been the
IDP camp life, where there was inadequate food for consumption (with resultant
malnutrition) [31, 32, 35] or infection with Onchocerca volvulus which afflicted
nearly 80% of NS children or psychological stress [1, 4, 17]. Other stressors could
have been severe illnesses such as malaria, meningitis, cholera and others which
were common in the IDP camps and affected a large number of IDP residents [2, 35,
44]. On the other hand profound biotinidase deficiency is a more severe and can
cause seizures, weak muscle tone (hypotonia), breathing problems, hearing and
vision loss, problems with movement and balance (ataxia), skin rashes, hair loss
(alopecia) and fungal infection particularly candidiasis [40–43]. The affected chil-
dren with biotinidase deficiency also have delayed development miles stones [40–
43]. Most of these symptoms and signs were similarly observed in NS children in
Northern Uganda.
The clinical presentations of NS children examined in 2012 and repeated in 2014
as part of a longitudinal study are similar to the clinical presentations of biotinidase
deficiency [39]. However, hearing and vision loss which are typically seen in pro-
found biotinidase deficiency were not observed in 2014 perhaps due to 2 years of
rehabilitation where it is suspected that the symptoms and signs which were akin to
profound biotinidase activity deficiency could not all be observed [39]. It is
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important to note that biotinidase functions by recycling the vitamin biotin which is
also known as vitamin B7 and it is bound to amino groups of lysine residues of
apoenzymes [41–43, 45]. If levels of serum biotinidase are low then biotin cannot be
broken down and released from proteins into the diet [41–43, 45]. In addition,
biotin serves as a coenzyme for four carboxylases enzymes; propionyl-CoA
carboylases & β-methyl crotonyl-CoA carboxylases, which are important in protein
catabolism; pyruvate carboxylases, which are essential for gluconeogenesis and
acetyl CoA carboxylases, which are involved in the first step in fatty acid synthesis
[42, 45]. Similarly, the majority of the NS children had deficiency of the acetyl
carnitine, a metabolite responsible for the transfer of short chain fatty acids into the
mitochondrium for metabolism and this perhaps represented the view that at the
time of stress, NS children were unable to utilize the short chain fatty acids and
perhaps with the resultant observed clinical features. Similarly, a previous study
had noted a near significant association between NS and pyridoxine deficiency
(Bunga’s study (p = 0.06)) [11].This finding was very important as seizures are
normally associated with abnormal pyridoxine metabolism [11].
In the same study, the levels of serum urate were overall unremarkable, dem-
onstrating that NS wasn’t perhaps associated with abnormalities involving purine or
pyrimidine metabolism [16]. The urate/creatinine ratio levels were lower than
normal range, suggesting that NS was not probably associated with rhabdomyolysis
[16]. In addition, it was previously observed by another author that NS was associ-
ated with vitamin D deficiency in which 7 out of 8 NS cases had reported vitamin
D deficiency [17]. Furthermore, findings from other studies indicate that the levels
of organic acid in urine were generally high and this was consistent with other
findings of high anion gap metabolic acidosis seen in NS patients in a case control
study [1]; case series [17]; case reports [10, 15] and clinical studies [39].
Therefore, NS in South Sudan & Northern Uganda represents an emerging
neurological disorder where investigations searching for potential environmental
toxins have not yet been fully conducted [4, 29, 46]. It is reported that thousands of
pesticides, solvents and other industrial chemicals have not been tested for
neurodevelopmental toxicity in the community where NS occurs at epidemic pro-
portions [46]. Historically, it has taken several decades of scrutiny to confirm
developmental neurotoxicity secondary to industrial chemicals following initial
clinical diagnosis of poisoning [47]. In South Sudan in 2011, CDC study collected
urine and blood and did analysis for heavy metals; however the preliminary analysis
of blood and urine results remains unpublished [48]. Bunga’s (2011) Sudanese
unpublished study mentioned in Dowell et al.’s study, found no abnormality
detected in the urine for mercury, thiocyanate and arsenic [11]. Foltz et al., tested
serum for copper and urine for homocysteine & thiocyanate levels [49]; Sevjar et al.
reported to have had an unremarkable toxin analysis (data not shown) [50]. The
vast majority of investigations into possible neurotoxic causes to NS children came
from information regarding diet, collected via questionnaires from NS caregivers
[14, 18, 46, 51–54]. There have been associations that have been demonstrated
between eating red sorghum and NS in a South Sudan study [46]. It has also been
further reported that there is an unidentified associated with mycotoxins which was
suggested as a likely putative agent [4, 29, 46]. Interestingly to date, there is no
published laboratory microbiological or neurotoxicological analysis of food that was
eaten in the IDPs camps to confirm these hypotheses. Further to this, NS in South
Sudan and Northern Uganda is suspected to be caused by a chemical neurotoxin
from war munitions used during the civil wars [8, 9, 46]. However, there are no
published studies investigating quantifiable war munitions and/or chemicals as
possible cause(s), despite several case control studies demonstrating a positive
association with exposure to war munitions and gun raids [11, 46, 49]. However, a
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recent case series in Northern Uganda found that all NS children had been exposed
to either severe war-related psychological and physical trauma and that most of
those interviewed in an observational study laid blame on war munitions/chemicals
[8, 55]. These findings showed that the environmental exposures of the affected
communities were reported although not proven but still forms a basis for hypoth-
esis that it could be a factor that could not be ignored in the epidemiology of NS in
Northern and South Sudan.
5. Experience of treatment and rehabilitation of children with nodding
syndrome
The treatment and rehabilitation responses of NS children in Northern Uganda
by Hope for HumaNs (HfH) has registered positive outcome with improved mid
upper arm circumference (MUAC), height, weight and hematological indices [39].
The comprehensive rehabilitation approach (correcting protein-energy using
MAMA nutritional food supplements and vitamin-related malnutrition, de-
worming, oral fungicide, anti-seizure medications (sodium valproate with/or with-
out Carbamazepine); close monitoring; tailored dosing and adjustments; special
needs education program; counseling) pioneered by HfH at Odek rehabilitation
centre has proven clinically transformative (steady growth, improved emotional
and marked seizure reduction status—though greater among males than females for
unknown reasons) [3, 4, 38]. It was still noted though that cognitive, behavioral
problems and social difficulties still confronted these NS children even 9 months
after rehabilitation at the HfH centre [39].
6. Nodding syndrome (NS), biotinidase and acetyl carnitine deficiency
and autism spectrum disorder (ASD)
Although autism spectrum disorder (ASD) was originally thought to be a static,
inheritable neurodevelopmental disorder, its understanding is currently undergoing
a major shift [45]. It is now emerging as a dynamic system of metabolic and
immune anomalies involving many organ systems, including the brain and envi-
ronmental exposures [45, 56]. The initial detailed observation and inquiry on
patients with ASD and related conditions, the histories of their caregivers and
families have been providing important information [45]. To date, it is not yet clear
how gastrointestinal (GI) factors are related to ASD [45, 56] however, many
patients with ASD have a history of previous antibiotic exposure or hospitalization,
GI symptoms, abnormal food cravings and unique intestinal bacterial populations,
which have been proposed to relate to variable symptom severity [45, 57]. An
author recently recommended that new approaches would be required to examine
the diverse symptoms and co morbidities of this growing family of neurodeve-
lopmental disorders known as autism spectrum disorder [45]. It is reported that
neurochemical changes which is consistent and predictive with findings in ASD
patients, including neuroinflammation, increased oxidative stress, mitochondrial
dysfunction, glutathione depletion and altered phospholipids/acylcarnitine profiles,
have been observed [45, 57]. In addition, propionic acid have been reported to have
bioactive effects on; neurotransmitter systems; intracellular acidification and cal-
cium release; fatty acid metabolism; gap junction gating; immune function and
alteration of gene expression that warrant further exploration [45]. Furthermore,
other authors have proposed that traditional scientific experimentation was
required to verify the hypothesis that enteric short-chain fatty acids may be a
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potential environmental trigger in some forms of ASD [45, 56, 58]. Interestingly,
the collaborative developments in systems biology particularly examining the role
of microbiome and its effects on host metabolism, immune and mitochondrial
function and gene expression, is reported to hold a great promise in investigation on
ASD [23, 45, 58–61]. It is further suggested that the microbiome produces an array
of bioactive metabolic products capable of entering systemic circulation [23, 45, 61].
Other authors have suggested that enteric microbiome and its metabolic products
were dynamic and could be altered throughout an individual’s life cycle, particularly
during the first 18 months of life [57–60, 62]. In addition, it was reported that the
metabolic products from the GI tract microbiome could have profound and
dynamic effects on host metabolism, immune functions and gene expressions which
happens in many organ systems including the CNS [58]. Furthermore, other
authors recommended that it was important to consider the effects of infant for-
mula versus breastfeeding, a high-calorie Western diet and exposure to antibiotics
and disinfectants in human beings, animals and plants on the alteration of the
human microbiome and its metabolites [45, 54, 56, 63, 64]. These should be con-
sidered a possible source of environmental triggers of many diseases of increasing
incidence including ASD [45]. This was particularly evident from human
populations who migrated to Western societies, such as the Somalis in the diaspora,
who appeared to have a much higher incidence of ASD than it existed in their
country of origin [45, 65].
Furthermore, there are examples of this experience in biology to show that it
may be possible that GI biome could alter the behaviors of animals [45, 66–68].
Examples; Rabies and Bornavirus infect the CNS in animals and induce aggression
that spreads the virus in the saliva from one animal to another through biting
behaviors [45]; Cordyceps (Ophiocordyceps unilateralis) is a fungal infection that
affects the behavior of ants, causing them to climb to the top of plants before they
die [45]. The resulting fruiting bodies of the fungus then sprout out of the dead
insect to spread spores [45]; in addition,Toxoplasmosis causes rodents to act without
an appropriate fear response, leading to transmission of the infectious agent
through cats via predation and ultimately on to humans [45]; Furthermore, Mun-
dane acts such as sneezing with a common cold or increased gastric motility leading
to nausea and vomiting in viral gastroenteritis are said to be in the best interest of
spreading the infectious agent [45]. The researcher then ponders whether similar
things that happen such as carbohydrate craving, diarrhea and fecal smearing in
ASD helps to feed and spread bacteria? [45]. It was observed that families of ASD
children just like NS children often become more alienated when they are told about
their children’s regression condition and that there was not much that could be done
[45] and they were often encouraged to use medications to partially reduce aggres-
sive behavior and to wait for their turn for the under-funded behavioral interven-
tion programs that take years to begin and years to complete [45, 56]. The strain and
stress of dealing with these children can destroy families and end productive
careers, leading desperate and vulnerable parents to turn to unproven controversial
treatments that can be costly, potentially dangerous and without confirmed effec-
tiveness [45]. This has been observed in parents of children with NS who have in
their helplessness resorted to the use of traditional medicines including and not
limited to the use of crashed roots, traditional medicines, witchcrafts, prayers, visits
to shrines and animal sacrifices as remedies for the treatment of this syndrome
[10, 15, 46, 50]. In addition, there are new interesting issues to learn about some
observations of bizarre food cravings, GI symptoms, epilepsy, infectious processes
and metabolic disturbances in children affected with ASD [45, 68–70] just like for
the NS children. However, there were reports that some ASD children appeared to
improve, either spontaneously, after certain broad spectrum antibiotics, or possibly
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by altering their diet [45]. This particular scenario has been observed in NS children
at the HfH rehabilitation centre in which NS children whose feeding pattern (using
a locally prepare MAMA food supplement) and symptomatic treatment have made
them improve physically but still confronted with cognitive, emotional and percep-
tual difficulties [3, 4, 38, 39]. A researcher wonders whether there might be a
common digestive system link to these findings even if current understanding in
conventional western medicine could do little for these ASD and NS children. The
mitochondrial disorders observed in ASD—studied extensively by Dan Rossignol,
Rossignol Medical Center, Irvine, California, and Richard Frye, University of
Arkansas, appeared to occur largely through environmental and not inherited
means [45, 71, 72]. It is reported that these disorders observed might be caused by
or at least worsened by enteric short-chain fatty acids including propionic acid from
GI tract bacteria [45, 57, 71, 72]. This is similarly a suggestion being advanced on NS
children seen in Northern Uganda and South Sudan because first, they were made
to feed on food provided by the relief agencies which were not their usual diet
during IDPs period (plumpy nuts, powdered milk, soya beans, red sorghum,
cooking oil which were sometimes of uncertain composition, rice, yellow posho and
other food substances that were made available to them) [3]. Secondly, there have
been consistent observation in case control studies, case series, case reports and
clinical and biochemical studies that NS children do have high anion gap metabolic
acidosis with depleted bicarbonate levels and one author proposed that the cause of
this syndrome may perhaps be due to mitochondrial disorders, a factor which may
be common to ASD and NS [1, 2, 10, 15, 50]. The cooking oil supplied and con-
sumed by the IDP residents provided by the relief agencies were not common to
their GI microbiome but may have perhaps been those of short chain fatty acids
[1–3, 5].
Furthermore, the reported collaborative work of Dr. Frye, who reviewed his
ASD patient population and found a large subset with the lipid (acylcarnitine) and
biochemical (citric acid, glutathione) findings predicted by the propionic rodent
model was another breakthrough in the advancement of science of ASD [45, 71–74].
His finding in June 2012, that there was an absence of genetic abnormalities to
explain these changes in ASD, suggesting that the biochemical findings stemmed
from environmental factors and were not inherited [45, 73, 74]. These similar
findings were observed in NS children in Northern Uganda where there have been
observed acetyl carnitine and biotinidase deficiency in a pilot study conducted on
NS children undergoing rehabilitation at the HfH centre [5].
In addition, a recently work with Bistra Nankova, from New York Medical
College, found that short chain fatty acids, including propionic acid are histone
deacetylase inhibitors and thus were switchers for genes particularly those involved
in the metabolism of catecholamines and was important in anxiety, arousal, move-
ment disorders, aggression and cravings [45]. This brings to mind a thought that
potentially bacteria can control and tinker with our metabolisms and even human
genes [45]. Additionally, some researchers now argue that these bacteria, through
natural selection, may be controlling or modulating our behavior and they may
serve the host well until environmental factors such as the Western diet or overuse
of antibiotics reset the microbiome to produce alterations of this behavior—the
obsessions, perseverations, food fixations and tics but also at times enhanced mem-
ory associated with ASD [45, 75–80].
The author argued that it was important to note that propionic acid affects
multiple systems at different developmental periods in a complex manner and that
the evidence of increased propionic acid or other short-chain enteric fatty acids
involved in the pathophysiology of ASD, although compelling, was still circum-
stantial [45, 77–79]. These researchers further reported that propionic and related
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short-chain fatty acids could elicit behaviors that are anxiety-like, perseverative,
repetitive, ritualistic and antisocial [80–84]. These behaviors were reported to be
common to many other neuropsychiatric conditions (obsessive compulsive, mood,
anxiety, attention deficit/hyperactive and eating disorders, irritable bowel syn-
drome, and schizophrenia) where infectious agents have been proposed [45, 81,
84]. In addition, the researchers argued that there was a growing incidence of ASD
and ASD-related conditions, coupled with the observed alterations in the human
microbiome secondary to dietary, medical and agricultural factors and their poten-
tial effects on human and animal behavior should be examined further [45, 58,
60, 81, 85, 86]. Professor Jared Diamond contended in his book Guns, Germs, and
Steel that the impact of human migration and urbanization, domestication of plants
and animals and resultant human diseases shaping cultures was not trivial [87]. He
further stated that, it was not so far-fetched to say that Western society has altered
human microbial populations, which in turn may be altering human behavior and
culture [87]. The similarities in the clinical presentations and the biochemical find-
ings in children with NS and ASD draws the attention of these researchers to
perhaps an understanding that NS may perhaps be a condition akin to autism
spectrum disorder (ASD); a disease spectrum that is not well understood but
continues to ravage the lives of many young people and families in developing and
developed world akin to the experience of NS in the East Africa. Nodding syndrome
were seen only in children who were born normal, lived in the IDP camps, were
from poor families, all ate food ration from relief agencies foreign to their GIT and
that all the children who developed NS were IDP resident at some stage in their lives
[2–5]. The relief agencies distributed various forms of cereals (Plumpy nuts, Beans,
soya, red sorghum, yellow posho, and maize) and cooking oil which were perhaps
foreign to their GI microbiome of the affected communities and the communities
ate them, they provided cooking oil whose constituents were foreign to the popula-
tion and they consumed them [2, 3, 33, 34]. In addition, NS children have been
found to have deficiency of Vitamin B6, Vitamin D, Acetyl carnitine and biotinidase
[5]. These factors point to the changes in the diet of the children and adults in these
communities where NS occurs at epidemic proportions during and after the war
and/or IDPs camp life which may have perhaps been partly responsible for the
syndrome that we have been investigating without finding the cause [2, 3, 5].
Important to note was that the Ugandan Ministry of Health and World Health
organization have since 2012 reported no new cases of NS in Northern Uganda since
the IDP camps were disbanded and communities returned to their farmland and
feed on their locally grown foods [2–5]. Therefore autism spectrum disorder, nod-
ding syndrome, biotinidase and acetyl carnitine deficiency [1–3, 5, 88] may be
conditions that share many things in common and this may be the right moment to
think of considering them as similar/common entities.
7. Conclusion
Nodding syndrome (NS) is a childhood neurological disorder that occurs in
clusters in Eastern Africa and of uncertain nosology. However, studies have dem-
onstrated biotinidase and acetyl carnitine deficiency, Vitamin B6 deficiency, high
anion gap metabolic acidosis and Vitamin D deficiency. In addition, NS children
experienced internal displacement, fed on IDP diets which were mainly foreign to
their GI microbiome and other environmental exposures, exposure to wartime
situations and infectious diseases at childhood. Rehabilitated of NS children using
home grown food supplement (MAMA supplement plus other symptomatic reme-
dies), their conditions improved tremendously and some have returned to school
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although there is no clear evidence that they have been completely cured. Further-
more, there are no new cases of NS as reported by the Ugandan Ministry of Health
(MOH) and World Health Organization (WHO) since 2012 when the IDP camps
were disbanded and communities resettled in their own communities and feed on
their own home grown foods. Although these findings are inconclusive at this stage,
perhaps NS observed in this region may be akin to autism spectrum disorder (ASD).
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